Understanding Osaka mutation polymorphic Aβ fibril response to static and oscillating electric fields: insights from...

Area of Science:

• Neuroscience
• Biophysics
• Computational Biology

Background:

• Alzheimer's disease (AD) is a major neurodegenerative disorder characterized by amyloid-beta (Aβ) plaque accumulation.
• Misfolded Aβ peptides self-assemble into toxic fibrils, driving AD progression.
• Polymorphic Aβ fibril structures, like the Osaka mutation (E22Δ), are particularly stable and toxic.

Purpose of the Study:

• To investigate the effect of static and oscillating electric fields on a polymorphic Aβ fibril.
• To determine the efficacy of specific electric field parameters in disrupting Aβ fibril conformation.
• To elucidate the molecular mechanisms behind electric field-induced Aβ fibril disruption.

Main Methods:

• Utilized molecular dynamics simulations.
• Employed a polymorphic fibrillar complex of Aβ1-40 peptide with the Osaka mutation (E22Δ).
• Applied static and oscillating electric fields with varying voltage and frequency (0.3-0.4 V/nm, 0.20 GHz).

Main Results:

• Oscillating electric fields at 0.3 V/nm and 0.4 V/nm with 0.20 GHz frequency effectively disrupted the polymorphic Aβ fibril conformation.
• Demonstrated the molecular mechanisms responsible for the disruption of Aβ fibril structure.
• Identified specific electric field parameters capable of destabilizing toxic Aβ aggregates.

Conclusions:

• Oscillating electric fields show potential as a novel therapeutic strategy for Alzheimer's disease.
• Disruption of Aβ fibril conformation via electric fields offers a new avenue for AD treatment.
• Further research into electric field-based therapies could lead to innovative treatments for neurodegenerative diseases.